A clinical study investigating the safety and efficacy of daikenchuto for the treatment of abdominal bloating.

Not Applicable

• Conditions: Patients with abdominal bloating

• Registration Number: JPRN-UMIN000016442
• Lead Sponsor: Izumo-City General Medical Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-02-04
• Study Completion: 2017-02-04
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up continuing
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Not provided

Exclusion Criteria

Patients receiving daikenchuto or other Japanese traditional herbal medicine within 4 weeks before enrolled in this study If not stable doses of the follow medications are taken for at least 2 weeks before enrolled to this study: acid suppressant, prokinetics, calcium polycarbophil, anticholinergic drug, laxative, antidepressant, anti-anxiety agent. Patients with organic lesion like cancer. Patients with serious coexisting disease (e.g. Hepatic, renal, cardiac, hematological, or metabolic disorder). Lactating or pregnant mother or women who wish to become pregnant during the study period. Determined not applicable for this study by the investigator.

Study & Design

• Study Type: Interventional
• Study Design: Not specified